AI
IDXX icon

Analytic Investors’s Idexx Laboratories IDXX Stock Holding History

Analytic Investors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-134,728
Closed -$8.64M – 597
2015
Q2 		$8.64M Sell
134,728
-544,348
-80% -$37.7M 0.12% 141
2015
Q1 		$52.5M Sell
679,076
-132,438
-16% -$10.3M 0.72% 44
2014
Q4 		$60.2M Buy
811,514
+4,978
+0.6% +$349K 0.85% 31
2014
Q3 		$47.5M Buy
806,536
+222,088
+38% +$14M 0.68% 43
2014
Q2 		$39M Buy
584,448
+167,694
+40% +$10.7M 0.63% 50
2014
Q1 		$25.3M Buy
416,754
+319,734
+330% +$19M 0.38% 76
2013
Q4 		$5.16M Buy
+97,020
New +$5.11M 0.09% 172

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Analytic Investors's IDXX Position: Q3 2015 in Review

Analytic Investors sold out of Idexx Laboratories (IDXX) in Q3 2015, closing a stake of 134,728 shares — an estimated $8.64M sold.

Analytic Investors first reported a position in IDXX in Q4 2013 and held it in 7 quarters. The position peaked at $60.2M in Q4 2014. 357 funds tracked by Wall St. Rank hold IDXX as of Q3 2015.

  • Analytic Investors reported no remaining Idexx Laboratories position as of Q3 2015 after selling out during the quarter.
  • Analytic Investors sold 134,728 Idexx Laboratories shares in Q3 2015, an estimated $8.64M.
  • Analytic Investors first reported a position in Idexx Laboratories in Q4 2013 and held it in 7 quarters.
  • Analytic Investors's Idexx Laboratories position peaked at $60.2M in Q4 2014.
  • 357 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2015.

Based on Analytic Investors's 13F filing for Q3 2015, filed 12 Nov 2015.